Dacarbazine Injection, Powder, For Solution
Product Images NDC 63323-127

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dacarbazine (NDC 63323-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (Dacarbazine 102820 Vial)

Vial (Dacarbazine 102820 Vial)
Dacarbazine 200 mg injection label for intravenous use, USP, prepared as the citrate salt. The label specifies single dose vial, Rx only, to discard unused portion. It includes sterile filter, storage instructions (20 to 25C or 68 to 77F), and a caution for natural rubber latex. Labeler is APP Pharmaceuticals, LLC.*
FDA Label Image
FDA Label Image

Structure (Dacarbazine Structure)

Structure (Dacarbazine Structure)
Chemical structure of dacarbazine showing its molecular composition including dimethylamino groups, triazene ring, and an amide functional group, corresponding to the active ingredient dacarbazine in the product.*
FDA Label Image

Vial (Dacarbazine Vial)

Vial (Dacarbazine Vial)
Dacarbazine 100 mg injection, powder for solution label for intravenous use. The label indicates the drug is prepared as the citrate salt in a single-dose vial, with instructions for reconstitution and storage at 2 to 8 degrees Celsius. The labeler is Fresenius Kabi USA, LLC, with relevant NDC codes and lot number area visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.